FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Dr. Reddy's Quetiapine Fumarate Tablets Recall

Dr. Reddy's Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets. Mfd By: Dr. Red…

Dr. Reddy's Laboratories, Inc. · Bridgewater, NJ

Risk level
Class II
Reported by FDA
Nov 28, 2012
Recall ID
D-059-2013
Check your lot numberHow we source this data

Summary

Dr. Reddy's Laboratories recalled Dr. Reddy's Quetiapine Fumarate Tablets starting Sep 27, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-059-2013 on Nov 28, 2012. Reason: Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg. Status: Terminated.

Why it was recalled

Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.

Product description

Dr. Reddy's Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets. Mfd By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325, India NDC 55111-249-05

Lot numbers, UPCs & expiration codes

Lot C203090 Exp.03/14

Where it was sold

Nationwide. No foreign consignees.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-059-2013
Classification
Class II
Status
Terminated
Recall initiated
Sep 27, 2012
FDA report date
Nov 28, 2012
Quantity
1512 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Dr. Reddy's Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-059-2013, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Terminated
Country
United States
Event ID
63524
Address
200 Somerset Corporate Blvd Fl 7th
Code information
Lot C203090 Exp.03/14
Postal code
08807-2862
Report date
Nov 28, 2012
Product type
Drugs
Recall number
D-059-2013
Classification
Class II
Recalling firm
Dr. Reddy's Laboratories, Inc.
Product quantity
1512 bottles
Termination date
Jul 10, 2013
Reason for recall
Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dr. Reddy's Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets. Mfd By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325, India NDC 55111-249-05
Distribution pattern
Nationwide. No foreign consignees.
Recall initiation date
Sep 27, 2012
Initial firm notification
Letter
Center classification date
Nov 20, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-059-2013, published Nov 28, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls